Abnormalities of the genital tract following stilbestrol exposure in utero.
D000014:Abnormalities, Drug-Induced / Q000473:pathology; D000230:Adenocarcinoma / Q000139:chemically induced / Q000175:diagnosis; D000293:Adolescent; D000328:Adult; D000818:Animals; D002584:Cervix Uteri / Q000002:abnormalities*; D002648:Child; D004054:Diethylstilbestrol / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced / Q000175:diagnosis; D014621:Vagina / Q000002:abnormalities*; D014625:Vaginal Neoplasms / Q000139:chemically induced / Q000175:diagnosis
D004054:Diethylstilbestrol